| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 7.160 | 23.788 | 21.444 | 17.247 | 25.767 | 3.982 | 724 | 1.067 | 202.668 |
| Total Income - EUR | - | 7.160 | 23.788 | 21.444 | 17.247 | 25.767 | 3.982 | 777 | 1.067 | 202.668 |
| Total Expenses - EUR | - | 5.580 | 8.177 | 10.545 | 5.284 | 2.465 | 2.179 | 11.460 | 13.831 | 28.002 |
| Gross Profit/Loss - EUR | - | 1.580 | 15.611 | 10.899 | 11.963 | 23.302 | 1.804 | -10.683 | -12.764 | 174.665 |
| Net Profit/Loss - EUR | - | 1.365 | 15.158 | 10.685 | 11.595 | 22.604 | 1.698 | -10.705 | -12.764 | 168.732 |
| Employees | - | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Dermomed Bistrita S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 43.169 | 35.213 | 43.156 |
| Current Assets | - | 1.456 | 15.657 | 16.661 | 17.544 | 28.706 | 18.845 | 255 | 2.013 | 256.729 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 122 | 0 | 0 | 0 | 3.496 | 3.446 | 0 | 0 | 107.890 |
| Cash | - | 1.334 | 15.657 | 16.661 | 17.544 | 25.210 | 15.399 | 255 | 2.013 | 148.839 |
| Shareholders Funds | - | 1.410 | 15.208 | 16.202 | 17.368 | 28.686 | 18.832 | 8.185 | -4.603 | 164.154 |
| Social Capital | - | 45 | 44 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | 47 | 449 | 460 | 176 | 20 | 13 | 35.239 | 41.829 | 135.731 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermomed Bistrita S.r.l.